SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-057094
Filing Date
2015-02-23
Accepted
2015-02-23 07:01:02
Documents
4
Period of Report
2015-02-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d878365d8k.htm 8-K 15491
2 EX-99.1 d878365dex991.htm EX-99.1 324149
3 GRAPHIC g878365im1.jpg GRAPHIC 11860
4 GRAPHIC g878365im2.jpg GRAPHIC 7194
  Complete submission text file 0001193125-15-057094.txt   367530
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 15637574
SIC: 2834 Pharmaceutical Preparations